TY  - JOUR

T1  - Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology
A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology

JO  - EuroIntervention

UR  - https://doi.org/10.4244/eij-e-26-00003

PY  - 2026/06/15

AU  - Gorog DA

AU  - ten Berg JM

AU  - Campo G

AU  - Geisler T

AU  - Gigante B

AU  - Grove EL

AU  - Halvorsen S

AU  - Huber K

AU  - Jeong Y-H

AU  - Lip GYH

AU  - Navarese EP et al

ED  - 

DO  - DOI: 10.4244/eij-e-26-00003

PB  - Europa Digital & Publishing

VL  - 22

IS  - 12

SP  - e653

EP  - e677

Y2  - 2026/07/16

ER  -